Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013526487> ?p ?o ?g. }
- W3013526487 endingPage "101674" @default.
- W3013526487 startingPage "101674" @default.
- W3013526487 abstract "Pioglitazone (PGL) is a hypoglycemic therapeutic agent used in the treatment of diabetes (type 2). The present research work was designed to prepare and optimize PGL loaded solid lipid nanoparticles (SLNs). The formulation was optimized using three factors lipid (Compritol® 888 ATO - A), surfactant (tween80- B) and homogenization speed (C), and their effects were evaluated on particle size (Y1in nm) and encapsulation efficiency (Y2in %). The optimized formulation (PGL-SLNopt) was further evaluated for physicochemical characterization, drug release, stability study, in–vivo antidiabetic and biochemical study. The optimized formulation PGL-SLNopt prepared with the composition of Compritol® 888 ATO (4.5% w/v), tween 80 (3.0% w/v) and homogenization speed (3800 rpm). The PGL-SLNopt hasshown particle size, EE, PDI, and zeta-potential 180.65 nm, 85.34%, 0.231 and −30.7 mV, respectively. The DSC and XRD spectra did not showed any peak of PGL confirm the complete entrapment of PGL in lipid due to solubilization. PGL-SLNopt exhibited significant (P < 0.05) prolonged release (89.56 ± 3.11% in 12 h) than pure PGL. The anti-diabetic study indicated that PGL-SLNopt showed significantly (P < 0.05) higher hypoglycemic activity (57.6% reduction in 12 h) as well as improved biochemical parameters. Our finding results revealed that PGL-SLNs could be a potential delivery system for the management of diabetes (type-2)." @default.
- W3013526487 created "2020-04-03" @default.
- W3013526487 creator A5002737277 @default.
- W3013526487 creator A5003677451 @default.
- W3013526487 creator A5021596422 @default.
- W3013526487 creator A5030640267 @default.
- W3013526487 creator A5030796965 @default.
- W3013526487 creator A5051338330 @default.
- W3013526487 creator A5056582640 @default.
- W3013526487 creator A5063508270 @default.
- W3013526487 creator A5064484330 @default.
- W3013526487 creator A5065678461 @default.
- W3013526487 creator A5067770639 @default.
- W3013526487 creator A5079714877 @default.
- W3013526487 creator A5085657354 @default.
- W3013526487 date "2020-06-01" @default.
- W3013526487 modified "2023-10-16" @default.
- W3013526487 title "Development of solid lipid nanoparticle as carrier of pioglitazone for amplification of oral efficacy: Formulation design optimization, in-vitro characterization and in-vivo biological evaluation" @default.
- W3013526487 cites W1990089345 @default.
- W3013526487 cites W1990578223 @default.
- W3013526487 cites W1997511894 @default.
- W3013526487 cites W2011819473 @default.
- W3013526487 cites W2017317942 @default.
- W3013526487 cites W2020267609 @default.
- W3013526487 cites W2023942206 @default.
- W3013526487 cites W2067407703 @default.
- W3013526487 cites W2068471000 @default.
- W3013526487 cites W2069235788 @default.
- W3013526487 cites W2078567611 @default.
- W3013526487 cites W2083634586 @default.
- W3013526487 cites W2114190473 @default.
- W3013526487 cites W2131860317 @default.
- W3013526487 cites W2204153331 @default.
- W3013526487 cites W2204416339 @default.
- W3013526487 cites W2252760452 @default.
- W3013526487 cites W2288601399 @default.
- W3013526487 cites W2312208367 @default.
- W3013526487 cites W2610719290 @default.
- W3013526487 cites W2724768241 @default.
- W3013526487 cites W2774580458 @default.
- W3013526487 cites W2789509226 @default.
- W3013526487 cites W2791372582 @default.
- W3013526487 cites W2793018507 @default.
- W3013526487 cites W2804220147 @default.
- W3013526487 cites W2830190460 @default.
- W3013526487 cites W2896399282 @default.
- W3013526487 cites W2899764361 @default.
- W3013526487 cites W2911570247 @default.
- W3013526487 cites W2911573799 @default.
- W3013526487 cites W2912709516 @default.
- W3013526487 cites W2927342574 @default.
- W3013526487 cites W2991602328 @default.
- W3013526487 doi "https://doi.org/10.1016/j.jddst.2020.101674" @default.
- W3013526487 hasPublicationYear "2020" @default.
- W3013526487 type Work @default.
- W3013526487 sameAs 3013526487 @default.
- W3013526487 citedByCount "22" @default.
- W3013526487 countsByYear W30135264872020 @default.
- W3013526487 countsByYear W30135264872021 @default.
- W3013526487 countsByYear W30135264872022 @default.
- W3013526487 countsByYear W30135264872023 @default.
- W3013526487 crossrefType "journal-article" @default.
- W3013526487 hasAuthorship W3013526487A5002737277 @default.
- W3013526487 hasAuthorship W3013526487A5003677451 @default.
- W3013526487 hasAuthorship W3013526487A5021596422 @default.
- W3013526487 hasAuthorship W3013526487A5030640267 @default.
- W3013526487 hasAuthorship W3013526487A5030796965 @default.
- W3013526487 hasAuthorship W3013526487A5051338330 @default.
- W3013526487 hasAuthorship W3013526487A5056582640 @default.
- W3013526487 hasAuthorship W3013526487A5063508270 @default.
- W3013526487 hasAuthorship W3013526487A5064484330 @default.
- W3013526487 hasAuthorship W3013526487A5065678461 @default.
- W3013526487 hasAuthorship W3013526487A5067770639 @default.
- W3013526487 hasAuthorship W3013526487A5079714877 @default.
- W3013526487 hasAuthorship W3013526487A5085657354 @default.
- W3013526487 hasConcept C130217890 @default.
- W3013526487 hasConcept C134018914 @default.
- W3013526487 hasConcept C13965031 @default.
- W3013526487 hasConcept C147789679 @default.
- W3013526487 hasConcept C150903083 @default.
- W3013526487 hasConcept C155672457 @default.
- W3013526487 hasConcept C171250308 @default.
- W3013526487 hasConcept C185592680 @default.
- W3013526487 hasConcept C187530423 @default.
- W3013526487 hasConcept C18903297 @default.
- W3013526487 hasConcept C192562407 @default.
- W3013526487 hasConcept C199529486 @default.
- W3013526487 hasConcept C207001950 @default.
- W3013526487 hasConcept C2777180221 @default.
- W3013526487 hasConcept C2778384471 @default.
- W3013526487 hasConcept C2778722038 @default.
- W3013526487 hasConcept C2779820397 @default.
- W3013526487 hasConcept C43617362 @default.
- W3013526487 hasConcept C55493867 @default.
- W3013526487 hasConcept C555293320 @default.
- W3013526487 hasConcept C58226133 @default.
- W3013526487 hasConcept C71924100 @default.
- W3013526487 hasConcept C86181022 @default.